Cargando…

MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women

Breast tissue enhances on contrast MRI and is called background parenchymal enhancement (BPE). Having high BPE has been associated with an increased risk of breast cancer. We examined the relationship between BPE and the amount of fibroglandular tissue on MRI (MRI-FGT) and breast cancer risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brooks, Jennifer D., Christensen, Rebecca A. G., Sung, Janice S., Pike, Malcolm C., Orlow, Irene, Bernstein, Jonine L., Morris, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411561/ https://www.ncbi.nlm.nih.gov/pubmed/36008488 http://dx.doi.org/10.1038/s41523-022-00458-2

Ejemplares similares

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2018)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
por: Watt, Gordon P., et al.
Publicado: (2020)

Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)

MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
por: Amano, Yasuo, et al.
Publicado: (2017)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
por: Ko, Kyung Hee, et al.
Publicado: (2017)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Correction: Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score
por: Zhang, Michelle, et al.
Publicado: (2021)

MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival
por: Lo Gullo, Roberto, et al.
Publicado: (2020)

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis()
por: Ben-David, Merav A., et al.
Publicado: (2019)

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers
por: Vreemann, Suzan, et al.
Publicado: (2018)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment
por: Wengert, Georg J., et al.
Publicado: (2019)

Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging
por: Kawamura, Akiko, et al.
Publicado: (2015)

Harmonization of Quantitative Parenchymal Enhancement in T(1)‐Weighted Breast MRI
por: van der Velden, Bas H.M., et al.
Publicado: (2020)

Fully automatic classification of breast MRI background parenchymal enhancement using a transfer learning approach
por: Borkowski, Karol, et al.
Publicado: (2020)

Generalizable attention U-Net for segmentation of fibroglandular tissue and background parenchymal enhancement in breast DCE-MRI
por: Nowakowska, Sylwia, et al.
Publicado: (2023)

Evaluation of breast parenchymal density with QUANTRA software
por: Pahwa, Shivani, et al.
Publicado: (2015)

Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
por: Hu, Xiaoxin, et al.
Publicado: (2021)

Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer
por: Li, Jun, et al.
Publicado: (2019)

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement
por: Kim, Soo-Yeon, et al.
Publicado: (2020)

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI
por: La Forgia, Daniele, et al.
Publicado: (2021)

Correlation Between Mammographic Breast Density, Breast Tissue Type in Ultrasonography, Fibroglandular Tissue, and Background Parenchymal Enhancement in Magnetic Resonance Imaging
por: Alikhassi, Afsaneh, et al.
Publicado: (2018)

Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
por: Hu, Na, et al.
Publicado: (2021)

Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer
por: Hu, Xiaoxin, et al.
Publicado: (2016)

Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography: Influence of Age, Breast Density, Menstruation Status, and Menstrual Cycle Timing
por: Zhao, Shuang, et al.
Publicado: (2020)

DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence
por: Wu, Shandong, et al.
Publicado: (2017)

Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
por: Moliere, Sebastien, et al.
Publicado: (2019)

Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2018)

Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response
por: Nguyen, Alex Anh-Tu, et al.
Publicado: (2022)

The Association between Breast Tissue Optical Content and Mammographic Density in Pre- and Post-Menopausal Women
por: Blackmore, Kristina M., et al.
Publicado: (2015)

Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2016)

Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy()
por: Chen, Jeon Hor, et al.
Publicado: (2015)

Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer
por: Begg, Colin B, et al.
Publicado: (2015)

Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study
por: Wang, Jeff, et al.
Publicado: (2015)

The Role of Diffusion-Weighted Imaging Based on Maximum-Intensity Projection in Young Patients with Marked Background Parenchymal Enhancement on Contrast-Enhanced Breast MRI
por: Park, Ga-Eun, et al.
Publicado: (2023)

The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study
por: Knight, Julia A., et al.
Publicado: (2018)

The relationship between breast density and bone mineral density after menopause
por: Cho, Jae-Hwan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ko2pvoqgnnj21ak81d0q0hirmv